The Big Money Behind Kentucky AG Daniel Cameron's Bizarre Psychedelic Drug Ibogaine Crusade

The inside story about a state commission that wants to spend $42 million on a controversial psychedelic drug to treat opioid addiction—and the complicated reasons why.

Related Keywords

Ohio ,United States ,Kentucky ,Mexico ,Germany ,Louisville ,New Zealand ,Texas ,Peru ,Pennsylvania ,University Of Kentucky ,Americans ,American ,Kentuckians ,German ,America ,Jeff Yass ,Melissa Etheridge ,Martin Steele ,Andy Beshear ,Linda Blackford ,Deborah Mash ,Peter Thiel ,Mitch Mcconnell ,Sharon Walsh ,Rick Perry ,W Bryan Hubbard ,Bryan Hubbard ,Journalsaid Paul ,Daniel Cameron ,Srinivas Rao ,Lamar Odom ,Rex Elsass ,Sally Hauser ,Exchange Commission ,University Of Miami School Medicine ,Strategy Group ,Drug Administration ,School Freedom Fund ,Etheridge Foundation ,Kentucky Ibogaine Initiative ,Linkedin ,Election Commission ,Life Sciences ,Susquehanna International Group ,Justice Department ,Opioid Abatement Advisory Commission ,Kentucky Attorney General Daniel Cameron ,Daily Beast ,Federal Election Commission ,Cameron Appointed Bryan Hubbard ,Brett Waters ,Reason For Hope ,Tom Daschle ,Breakthrough Therapies Act ,Kentucky Opioid Symposium ,Miami School ,Mind Medicine ,Breakthrough Therapies ,Marine Corps ,West Africa ,Texas Republican ,Cory Booker ,Rand Paul ,Louisville Courier Journalsaid Paul ,Freedom Fund ,Kentucky Lantern ,Protect Freedom ,Lexington Herald Leader ,Opioid ,